Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability

Jun Ge, Benxu Tan, Ye Chen, +17

Journal of Molecular Medicine

Food ChemistryBiochemistryMedicineDiminished Sunitinib BioavailabilityToxicology +7

Epidermal Growth Factor Receptor (EGFR)-RAS Signaling Pathway in Penile Squamous Cell Carcinoma

Hong-Feng Gou, Xiang Li, Meng Qiu, +14

PLoS ONE

Tumor BiologyBraf MutationMedicineKras MutationRare Kras Mutation +11

Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer

Xingchen Peng, Fanxi Gong, Yunfeng Chen, +7

Journal of Proteomics

Potential Therapeutic TargetProteomics IdentificationUrologyUrothelial Bladder CancerGenitourinary Cancer +6

Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: A phase 2 trial

Xin Wang, Yongyang Yu, Wenjian Meng, +19

Radiotherapy and Oncology

Surgical OncologyRadiation TherapyMedicineHigh Risk FactorsTotal Neoadjuvant Treatment +7

Factors Potentially Associated with Chemotherapy-induced Anemia in Patients with Solid Cancers

Ke Cheng, Feng Zhao, Feng Gao, +11

Asian Pacific Journal of Cancer Prevention

Expression Characteristics of Proteins of the Insulin-like Growth Factor Axis in Non-small Cell Lung Cancer Patients with Preexisting Type 2 Diabetes Mellitus

Jing Ding, Jie Tang, Xin Chen, +9

Asian Pacific Journal of Cancer Prevention

Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy

Tahir Zaib, Ke Cheng, Tingdang Liu, +10

International Journal of Molecular Sciences

Loss of RASSF1A Expression in Colorectal Cancer and Its Association with K-ras Status

Dan Cao, Ye Chen, Yuan Tang, +6

BioMed Research International

Prevalence and characteristics of anemia in patients with solid cancers at diagnosis in southwest China.

Feng Gao, Ke Cheng, Feng Zhao, +10

PubMed

S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial

Ye Chen, Jing Wu, Ke Cheng, +12

The Oncologist